Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Private placement
View:
Post by Matteo1234 on Sep 16, 2020 3:45am

Private placement

Expect another round @.025 for a million. The bottom line is the patents. Nitrous oxide helps with covid-19 through the nitrous oxide results from the new study for the response. Very confident that we can set something up for next few weeks
Comment by losingmyshirt on Sep 16, 2020 8:43am
You must be an idiot. Even my dog knows that nitric oxide works.INHALED. What don't you understand about R107? There are no trials of R107 and therefore we have nothing. 
Comment by Moonshiner592 on Sep 16, 2020 11:26am
  ... think about this - why would somebody as renouned as Salzman.. with the level of research he and his team have done .. want a worldwide patent in something he was NOT confident about???
Comment by Scotty on Sep 16, 2020 11:59am
"We" got a patent for GVHD too.
Comment by Radikal1 on Sep 16, 2020 12:07pm
This post has been removed in accordance with Community Policy
Comment by JMark80 on Sep 16, 2020 12:33pm
How many millions did the GvHD program cost shareholders?
Comment by Scotty on Sep 16, 2020 12:35pm
Good example of what? I don't think you're proving the point you think you are.
Comment by Radikal1 on Sep 16, 2020 12:45pm
This post has been removed in accordance with Community Policy
Comment by Scotty on Sep 16, 2020 12:57pm
So let me get this straight. According to the press releases, we could have gotten financing for GVHD, but, paraphrasing, KLY thought the offers were poor, so management held out. Instead, management allowed us to default after spending millions of investor money advancing the research, diluting the company and losing shareholder value. But that decision to get nothing rather than something ...more  
Comment by Radikal1 on Sep 16, 2020 1:05pm
This post has been removed in accordance with Community Policy
Comment by Scotty on Sep 16, 2020 1:10pm
Way to totally avoid the point. IMO, KLY is just a shell corp designed to publicly fund the research for these private companies then hand it back consequence free over some technicality. It doesn't matter how legit the research is, the investors won't see any returns.
Comment by Radikal1 on Sep 16, 2020 1:18pm
This post has been removed in accordance with Community Policy
Comment by JMark80 on Sep 16, 2020 1:31pm
The confirmation bias among pumpers is ridiculous. It's over - the market isn't interested.
Comment by Radikal1 on Sep 16, 2020 1:43pm
This post has been removed in accordance with Community Policy
Comment by JMark80 on Sep 16, 2020 2:10pm
No, the bashers are the only ones telling the truth. We know the last financing, the one they needed to keep the lights on, was undersubscribed at a discount to market, well after they announced the deal. 
Comment by Radikal1 on Sep 16, 2020 2:17pm
This post has been removed in accordance with Community Policy
Comment by Scotty on Sep 16, 2020 1:41pm
You didn't answer the question. Why was the decision to let KLY default and not try to salvage something from it's multi-million dollar investment a decision that shouldn't reflect poorly on KLY? All you said was CBD market conditions weren't favorable. Fine, a bad deal is better than none. Now we're just out that money and the company is a fiscal disaster. But like I said ...more  
Comment by Radikal1 on Sep 16, 2020 1:49pm
This post has been removed in accordance with Community Policy
Comment by Scotty on Sep 16, 2020 2:08pm
That question was definately implied in my first post, I suppose I should have made it clearer for you. Correct me if I'm wrong here, but your position is that "selling" GVHD back to talent for what we owed although we spent additional millions developing it, was just bad luck b/c of market conditions?
Comment by Radikal1 on Sep 16, 2020 2:13pm
This post has been removed in accordance with Community Policy
Comment by JMark80 on Sep 16, 2020 2:16pm
It wasn't market coniditions kiddo, it was incompetence.
Comment by Radikal1 on Sep 16, 2020 2:24pm
This post has been removed in accordance with Community Policy
Comment by JMark80 on Sep 17, 2020 10:49am
I'm talking about how the company was run - not their market cap, dumbass.
Comment by Scotty on Sep 16, 2020 2:24pm
You're assuming an awful lot. The GVHD research had a lot of potential, there could have been many many different ways this could have played out.. The best option KLY could come up with was to "sell" back a more developed asset at the original price? Leaving itself with literally nothing but the potential to possibly acquire another company, with another phase 1 drug that needs ...more  
Comment by Radikal1 on Sep 16, 2020 2:32pm
This post has been removed in accordance with Community Policy
Comment by Scotty on Sep 16, 2020 2:55pm
Yes and now Talent has their GVHD asset back, further developed I might add, and KLY shares. Strange how that worked out.
Comment by Radikal1 on Sep 16, 2020 5:50pm
This post has been removed in accordance with Community Policy
Comment by Scotty on Sep 16, 2020 8:51pm
Yes that is 100% correct. And that's the problem.
Comment by Radikal1 on Sep 16, 2020 10:31pm
This post has been removed in accordance with Community Policy
Comment by JMark80 on Sep 17, 2020 10:52am
Crash of the CBD sector? Are you serious? They deferred milestone with considerable interest long before they defaulted. Problem was they were undercapitalized, long before alleged CBD crash. 
Comment by JMark80 on Sep 17, 2020 10:55am
They wouldn't be able to pay phase 3 anyway. The fact they couldn't license had nothing to do with CBD market. They couldnt even raise capital for phase 2, which is why they paid Salzman in shares which they sold into open market. Too bad KLY screwed up on that $5mm IIA grant, huh? 
Comment by Matteo1234 on Sep 17, 2020 8:41am
Talent taking a big position in the stock is great news. A aknowledgement of strength.
Comment by JMark80 on Sep 17, 2020 10:53am
Talent? WTF are you talking about?
Comment by JMark80 on Sep 16, 2020 2:14pm
You don't even know what you don't know. Don't post, just learn.
Comment by JMark80 on Sep 16, 2020 1:21pm
Salzman knew Talent used 300mg of CBD in sesame oil when he acquired them. If anyone were interested, they probably knew Kalytera couldn't raise any more capital, and they could just make a deal with Talent for only a single digit royalty.
Comment by JMark80 on Sep 16, 2020 1:23pm
Salzman, like Farrell, was a terrible CEO.
Comment by JMark80 on Sep 16, 2020 12:31pm
Salzman was really confident about a lot of things when he was CEO, look what happened?
Comment by Scotty on Sep 16, 2020 9:02am
What I would like to know is: 1. How do you expect them to fill a PP for 1 million @ 2.5 when they couldn't fill 450k for 1.5 and 1/2 warrent? Nothing hew has come out, and let's be real here, probably nothing more to come except a rewording of what we already know. 2. Correct me if I'm wrong here, but if/when this starts trading again and it drops to ~1c on day 1, are they even able ...more  
Comment by JMark80 on Sep 16, 2020 9:57am
Exactly, they can't. 
Comment by Moonshiner592 on Sep 16, 2020 11:31am
... credibility will amplify after Phase 1 is complete .. which will knock the apostrophe 'T ... right out of that word "can't" !!     Hold those shares ...   
Comment by JMark80 on Sep 16, 2020 12:33pm
Uh huh, yeah I'm sure.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities